We investigated effects of different proportions of incongruent trials on behavioral and event-related potential (ERP) interference measures associated with response conflict in the Stroop and flanker task. From the literature, we hypothesized that response conflict is greater when incongruent trials are rare compared to when incongruent trials are frequent. In support, the behavioral results on both tasks and the ERP results on the Stroop task (N450) showed that interference effects were significantly larger when incongruent trials were rare than frequent. In contrast, the ERP results on the flanker task N200 showed a larger interference effect when incongruent trials were frequent than rare. Because results for the flanker N200 were opposite to behavioral effects and theoretical predictions, our findings challenge the notion of the flanker N200 as a valid index of response conflict.
Impaired bonding with the infant is associated with maternal postpartum depression but has not been investigated extensively in fathers. The primary study aim was to evaluate associations between maternal and paternal depressive symptoms and impaired bonding with their infant. A secondary aim was to determine the associations between parents' marital problems and impaired bonding with the infant. The study is part of a population-based cohort project (UPPSAT) in Uppsala, Sweden. The Edinburgh Postnatal Depression Scale (EPDS) at 6 weeks and 6 months postpartum and the Postpartum Bonding Questionnaire at 6 months postpartum were completed by 727 couples. The prevalence of impaired bonding was highest among couples in which both spouses had depressive symptoms. Impaired bonding was associated with higher EPDS scores in both mothers and fathers, as well as with experiencing a deteriorated marital relationship. The association between maternal and paternal impaired bonding and the mothers' and fathers' EPDS scores remained significant even after adjustment for relevant confounding factors. Depressive symptoms at 6 weeks postpartum are associated with impaired bonding with the infant at 6 months postpartum for both mothers and fathers. It is critical to screen for and prevent depressive symptoms in both parents during early parenthood.
The main aim of this study was to investigate the developmental course of motor response inhibition and execution as measured by the stop-signal task in a population-based sample of 525 4- to 12-year-olds. A further aspiration of the study was to enhance the limited knowledge on how the various stop-signal measures relate to ADHD behaviors in a normal sample. We also wanted to contribute to the theoretical understanding of the various stop-signal measures by examining the relations between the stop-signal measures and performance on tasks reflecting other aspects of response inhibition and execution. Our results showed that the ability to inhibit as well as to execute a motor response as measured by the stop-signal task improved with age during childhood. Of specific interest are the findings suggesting that this task captures the development of motor response inhibition in the late preschool years (age 5 years). Both of the inhibition measures derived from the stop-signal task (i.e., SSRT and probability of inhibition) related significantly to teacher ratings of inattention as well as to performance on tasks tapping other aspects of inhibition. The data provided by this study have thus contributed to the scarce knowledge on early development of motor response inhibition, as well as suggested that the stop-signal task may be a valuable tool for capturing deficient motor response inhibition in ADHD behaviors in normal samples.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.